Skip to content 
Researchers evaluating Kisspeptin-10 can compare the supplier documentation with the compound identity and published research. Kisspeptin-10 is a KiSS1-derived decapeptide associated with KISS1R, also called GPR54, receptor research [1] [2] . This guide covers identity, literature interpretation, COA review, analytical testing, labeling, and laboratory procurement.
- Kisspeptin-10 is a research peptide discussed as a C-terminal kisspeptin fragment in KISS1 and GPR54 literature [2] [3].
- Researchers evaluate this compound through peptide identity, molecular weight, peptide sequence, receptor context, and model-specific literature.
- A certificate of analysis should support batch-specific review, including purity, lot information, and testing methods.
- HPLC can support peptide purity review, while LC-MS can support identity-focused analytical verification [4] [5].
- Published literature can inform pathway context, but it should not be converted into product claims.
Fast Answer: What Should Researchers Check Before They Buy Kisspeptin-10 for Research?
Researchers looking to buy Kisspeptin-10 for research should first review RUO labeling, the compound name, lot-specific certificate of analysis, peptide purity data, identity testing, molecular weight, and handling and storage documentation. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption. Published literature should be treated as research context, not product-use guidance.
Kisspeptin-10 identity and traceability
Before you buy Kisspeptin-10 for research, compare the product label with its compound identity record and batch-specific analytical documentation. Record the lot number so that the received material remains traceable.
For Kisspeptin-10, that means reviewing peptide identity, COA availability, batch traceability, and literature context. PubChem lists Kisspeptin-10 with the formula C63H83N17O14 and a molecular weight near 1302.4 g/mol [1]. That type of identity information helps researchers compare the product listing against independent database records.
What Documentation Should Come First
The first documentation layer should be the product label and batch-specific certificate of analysis. The next layer should be analytical testing details, such as HPLC purity and LC-MS identity support when available. HPLC is widely used in peptide analysis and purification, especially for separating peptide material and related impurities [4].
A research buyer should also check that the lot number, compound name, and testing date are consistent. FDA Q7 guidance emphasizes quality systems, laboratory controls, and documentation principles for materials represented by quality characteristics [6].
Why RUO Labeling Matters Before Procurement
RUO labeling identifies the material as intended for laboratory research. Kisspeptin literature spans receptor biology, endocrine pathways, and model-specific findings [7] , but these studies do not establish suitability of the listed material for consumer use.
Kisspeptin-10 Research-Use-Only Evaluation
Compare the material’s identity, batch documentation, and research-use-only labeling before selection.
What Research Use Means for Kisspeptin-10
Research use means the compound is discussed for laboratory research purposes only. For Kisspeptin-10, the relevant context includes compound identity, receptor gpr54 literature, peptide sequence, in vitro research models, and analytical testing.
Kisspeptin peptides are described as products of the KISS1 gene and ligands for the G protein-coupled receptor GPR54, also called KISS1R [7] [8]. This is receptor research context only.
Why Research Buyers Need Documentation Over Claims
Check whether the peptide listing, COA, label, and lot details align. Evaluate these material records separately from academic findings.
What Is Kisspeptin-10 in Research Literature?
Kisspeptin-10 is generally discussed as a short kisspeptin peptide fragment. Official pharmacology resources list the peptide sequence as YNWNSFGLRF, with an amidated C-terminal phenylalanine [2].
Compound Identity and Research Classification
Kisspeptin-10 is a decapeptide associated with the kisspeptin family. The broader kisspeptin family includes kisspeptin-54 and shorter fragments produced from KISS1-related peptide biology [3]. The compound is commonly discussed in receptor and signal transduction literature.
How Kisspeptin Relates to Kisspeptin-10
Kisspeptin is the broader family term. Kisspeptin-10, also known as KP-10 in some literature, refers to a shorter fragment that retains the conserved C-terminal region discussed in receptor research [3]. This distinction matters because product documentation should identify the exact compound.
Why KP-10 Is Discussed as a Peptide Fragment
KP-10 is discussed as a peptide fragment because shorter kisspeptin peptides share the C-terminal sequence region associated with KISS1R interaction [2] [3]. For product-page research review, that makes sequence documentation and molecular weight especially important.
Molecular Identity for Kisspeptin-10 Peptide Review
Molecular identity is the foundation of Kisspeptin-10 peptide review. A research material should be evaluated against its compound name, formula, molecular weight, and sequence records.
Why Molecular Weight Matters for Documentation
Molecular weight helps researchers compare product documentation with independent compound references. PubChem lists Kisspeptin-10 at approximately 1302.4 g/mol [1]. A COA or product record should not conflict with the expected molecular identity.
How Peptide Sequence Supports Identity Review
The peptide sequence YNWNSFGLRF is listed for kisspeptin-10 by the IUPHAR Guide to Pharmacology [2]. Sequence review is useful because closely related kisspeptins and species-specific fragments can differ in structure.
Where C-Terminal Structure Fits Into Literature Context
The C-terminal region is central in kisspeptin fragment discussions. IUPHAR notes that the C-terminal phenylalanine is amidated for kisspeptin-10 [2]. This is a compound-identity detail, not a product claim.
Receptor Context for Kisspeptin-10 Research
Kisspeptin-10 research often appears in the context of KISS1R, also called GPR54. This receptor context helps researchers understand why the compound appears in neuropeptide and cell signaling literature.
What Researchers Should Know About GPR54
GPR54, also known as KISS1R, is a G protein-coupled receptor associated with kisspeptin ligand research [8]. Published reviews describe kisspeptins as peptide products of the KiSS-1 gene and natural ligands of GPR54 [7].
How KiSS1 and Kisspeptin Receptor Context Connect
The KiSS1 gene and kisspeptin receptor context are closely linked in the literature. Kotani and colleagues identified peptides encoded by the metastasis suppressor gene KiSS-1 as ligands of the previously orphan receptor GPR54 [9]. This is useful background for understanding receptor-pathway research.
What Do Receptor Studies Establish?
Receptor findings from a defined experiment do not establish effects of the listed material.
Cell Signaling Context in Laboratory Research
Kisspeptin and GPR54 are studied in cell signaling, receptor biology, and defined experimental systems.
What Does Kisspeptin-GPR54 Signaling Research Examine?
Published literature frames kisspeptin-GPR54 signaling as a receptor-ligand system. Reviews describe the system in relation to GnRH neuron signaling and endocrine pathway research [7] [10].
Where Signal Transduction Fits Into Research Models
Signal transduction refers to how receptor interaction is studied in model systems. In kisspeptin research, this may involve receptor activation, pathway mapping, and downstream signaling markers. These are research-model concepts, not claims about RUO material performance.
Why Pathway Relevance Is Not a Product Claim
A compound’s appearance in pathway research does not establish suitability of the supplied material for clinical, therapeutic, or consumer use.
Kisspeptin-10 and In Vitro Research Models
In vitro studies can characterize receptor and signaling questions under controlled laboratory conditions. Their findings do not establish effects of the supplied material.
What In Vitro Context Can Clarify
In vitro models can clarify receptor interaction, peptide response markers, and assay-specific pathway activity. Kotani and colleagues’ work helped define KiSS-1-derived peptide receptor biology in experimental contexts [9]. Such findings remain model-specific.
How Laboratory Settings Shape Interpretation
A cell model, receptor assay, or biochemical experiment shows what happened under specific conditions. It does not establish the same result for a different material or setting.
Why Model Design Matters for Research Findings
Model design affects what a study can show. A study may involve a particular cell line, receptor system, analytical method, or measurement window.
Published Literature Review for Kisspeptin Peptides
The kisspeptin literature is broad, so source quality matters. Researchers should separate original mechanistic studies, database records, reviews, analytical references, and vendor claims.
How Researchers Evaluate Source Quality
A safe source quality filter starts with official databases, peer-reviewed studies, and review articles. PubChem and IUPHAR support compound identity review [1] [2]. PubMed-indexed reviews support receptor and pathway context [7] [10].
What Literature Can and Cannot Establish
Literature can describe how a compound was studied, which models were used, and which receptors or pathways were examined. It does not establish effects of the catalog material. Human studies are outside the scope of RUO product use and should not be interpreted as a use claim for research-use-only materials.
How Do Named Sources Support Interpretation?
Named sources allow researchers to examine the evidence behind a statement. Tena-Sempere reviewed experimental evidence relating kisspeptins and GPR54 to GnRH regulation [7] . This provides pathway background, not evidence of effects of the supplied material.
Separating Published Findings From Product Documentation
Evaluate experimental findings separately from the records identifying and characterizing the supplied material.
Why Study Findings Should Not Become Product Claims
Study findings apply to the models, methods, materials, and limitations described. Receptor or pathway results do not establish effects of this catalog material.
Which Records Support RUO Material Evaluation?
Review molecular identity, the certificate of analysis, HPLC and LC-MS evidence, lot traceability, and RUO labeling together.
What Documentation Can Researchers Check?
Check the product name, lot number, purity and identity methods, COA date, label consistency, and handling and storage conditions.
Certificate of Analysis Review for Kisspeptin-10
A certificate of analysis is a key product-page document. It should support batch-specific review rather than serve as a marketing claim.
What a Certificate of Analysis Should Show
A COA should identify the tested material, lot or batch, testing method, result, and date. ICH Q7 guidance notes that quality documentation and laboratory controls are part of a broader quality system for materials with stated quality characteristics [11]. Research buyers should review whether the COA matches the product listing.
How COA Data Supports Research Procurement
COA data supports procurement by creating a record for review. It can show whether a batch was tested for purity and whether identity information is available. FDA Q7 Q&A guidance also notes that a supplier’s COA may not necessarily align with the user’s specifications, which supports independent review by the receiving organization [12].
Why Batch-Specific Documentation Matters
Batch-specific documentation matters because peptide materials can vary by lot. A COA should be tied to the batch being evaluated. A generic document is less useful than a lot-specific record with clear testing details.
Analytical Testing for Peptide Identity and Purity
Analytical testing helps researchers evaluate whether documentation supports the product listing.
How HPLC Supports Peptide Purity Review
High-performance liquid chromatography is used in peptide purification and analysis, including reversed-phase, ion-exchange, and size-exclusion modes [4]. In product documentation, HPLC can help review peptide purity by showing chromatographic separation and peak reporting.
How LC-MS Supports Identity Verification
LC-MS can support peptide identity review because mass spectrometry provides mass-related information that helps characterize peptides. LC-HRMS methods have been used for qualitative and quantitative identification and characterization of peptide-related materials and impurities [5].
What Chromatogram Review Adds to Documentation
Chromatogram review adds method-level transparency. It can help researchers see peak patterns, retention information, and reported purity. A chromatogram should be read alongside identity testing and batch documentation, not in isolation.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
|---|---|---|---|
| Compound identity | Formula, molecular weight, and database identity for Kisspeptin-10 [1] | Official database | Supports documentation review only |
| Receptor context | Kisspeptins as ligands for GPR54/KISS1R [7] | Peer-reviewed review | Supports pathway context only |
| Peptide sequence | YNWNSFGLRF and C-terminal amidation [2] | Official pharmacology database | Supports identity review |
| Purity review | HPLC methods for peptide analysis [4] | Analytical literature | Supports documentation review |
| Identity testing | LC-MS characterization of peptide materials [5] | Analytical literature | Supports identity-focused review |
Lot Traceability and Supplier Documentation
Lot traceability helps connect the product listing to the specific research material. It also helps technical teams organize procurement records.
Why Lot Numbers Matter for Research Peptides
Lot numbers matter because they connect labeling, COA, and batch records. Without lot traceability, a COA cannot be confidently matched to the product being reviewed. ICH Q7 emphasizes documentation systems, batch records, and laboratory controls as part of quality management [11].
What Research Buyers Should Compare Across Suppliers
Research buyers should compare documentation quality, not consumer claims. Useful comparison points include COA availability, test method disclosure, lot matching, identity data, storage notes, and RUO labeling.
How Documentation Consistency Supports Procurement Review
Documentation consistency reduces ambiguity. The compound name, molecular weight, lot number, and label should tell the same story. When documents conflict, researchers should resolve the discrepancy before procurement decisions are finalized.
Handling and Storage Documentation for RUO Materials
Retain handling and storage information in the laboratory record. Research material stewardship is separate from personal-use instructions.
What Handling and Storage Records Should Clarify
Handling and storage records should clarify storage conditions, label requirements, document retention, and batch identification. ICH Q7 includes guidance on storage, distribution, packaging, labeling, and laboratory controls for quality systems [11].
Why Lyophilized Material Documentation Matters
Lyophilized material documentation matters because freeze drying is commonly used to stabilize peptide materials for distribution. Record the physical form, label details, and supplier storage conditions.
How Labeling Consistency Supports Laboratory Review
Labeling consistency helps connect the vial label, product record, and COA. For Kisspeptin-10, the label should not conflict with the expected compound identity or lot documentation. Consistency is a procurement quality check.
Common Misunderstandings About Kisspeptin-10
What Does the 10mg Catalog Amount Mean?
A 10mg reference is a catalog or listing specification.
How Research Context Differs From Product-Use Language
Research literature describes experimental observations; analytical records describe tested material. Neither establishes directions or suitability for uses outside the RUO limitation.
Why Compound Research Is Not Consumer Guidance
Compound research is not consumer guidance. A receptor pathway, molecular target, or literature finding does not support personal-use positioning.
Research Procurement Checklist for Kisspeptin-10
A procurement checklist helps research teams evaluate Kisspeptin-10 documentation without relying on claims.
What Lab Teams Should Confirm Before Purchase
- Verify that the compound is labeled for research use only.
- Review the batch-specific certificate of analysis.
- Confirm that purity data are supported by an analytical method.
- Check that the lot number on the COA matches the product documentation.
- Compare compound name, molecular weight, and peptide sequence against authoritative references [1] [2].
- Assess whether the product page avoids clinical-use language, therapeutic language, and consumer outcome claims.
- Document handling and storage conditions in a laboratory record.
How to Compare COA, Labeling, and Literature Context
A strong review separates three layers. The COA supports batch-level analytical review. The label supports product identification and RUO positioning. Published literature supports scientific context, but it does not define the intended purpose of the listed research material.
Lab-test verification protocol:
- Verify the compound name, lot number, and label match across documents.
- Review the batch-specific COA.
- Check whether the purity testing method is listed.
- Confirm whether identity testing is supported by LC-MS or another suitable analytical method.
- Review chromatogram or mass data when available.
- Check the COA date and lab source.
- Document handling and storage requirements in a laboratory record.
Pure Lab Peptides supplies compounds for laboratory research use only. Products are not intended for human or animal consumption, diagnostic use, therapeutic use, clinical use, veterinary use, or as food, drugs, cosmetics, dietary supplements, or household products. Researchers are responsible for ensuring lawful, appropriate handling and use in accordance with applicable regulations and institutional guidelines.
Review the product-page documentation, COA details, and RUO labeling before evaluating this compound for laboratory research.
FAQs
What is Kisspeptin-10 in research literature?
Kisspeptin-10 is described in research literature as a decapeptide and peptide fragment within the broader kisspeptins family.
How Is Kisspeptin-10 Related to the Kiss-1 Pathway?
Kisspeptin-10 is discussed as a short peptide fragment associated with the Kiss-1 research pathway.
What role does Kisspeptin-10 play in receptor pathway research?
Kisspeptin-10 is discussed in KISS1R receptor-pathway literature. Interpret signaling and receptor-interaction findings within the published models and evaluate the supplied material separately through its characterization and lot records.
What should researchers consider before they buy Kisspeptin-10 for research?
Researchers should consider RUO labeling, batch-specific documentation, COA availability, identity review, supplier records, and consistency across product documentation.
Why are research models important for Kisspeptin-10 interpretation?
Research models are important because they define what a study can and cannot show. A receptor assay, in-vitro model, or pathway-focused experiment provides controlled research context, but those findings should not be translated into product claims or broader application statements.
Researchers Cited in This Guide
The researchers listed below are cited for relevant published work. Their inclusion does not imply that they wrote, reviewed, or endorsed this guide or Pure Lab Peptides products.
Manuel Tena-Sempere
Author profile: ORCID
Manuel Tena-Sempere is a research author whose publications are relevant to kisspeptin, GPR54, and neuropeptide pathway literature. His publications are useful for understanding how kisspeptins have been discussed across peptide signaling, Kiss-1, and GPR54 research contexts.
Selected publications:
- A review relevant to GPR54 and kisspeptin pathway literature — Human Reproduction Update, 2006. PMID: [16731583]
- A publication relevant to Kiss-1 and metabolic pathway research context — Molecular and Cellular Endocrinology, 2006. PMID: [16940711]
William H. Colledge
Author profile: University of Cambridge Profile
William H. Colledge’s published work concerns Kiss1, GPR54, and GnRH-neuron signaling models. His publications provide background for receptor-focused Kisspeptin-10 research.
Selected publications:
- A publication relevant to kisspeptins and GnRH neuronal signaling — Trends in Endocrinology & Metabolism, 2009. PMID: [19097915]
- A publication relevant to GPR54 pathway research — Reviews of Reproduction, 2004. PMID: [15519892]
REFERENCES
- National Center for Biotechnology Information. Kisspeptin-10 compound record. PubChem. Updated 2026.
- IUPHAR/BPS Guide to Pharmacology. Kisspeptin-10 ligand structure record. Guide to Pharmacology database.
- Colledge WH. GPR54 and kisspeptins. Results and Problems in Cell Differentiation. 2008. PMID: 18193176.
- Mant CT, Hodges RS. HPLC analysis and purification of peptides. Methods in Molecular Biology. 2007.
- Zeng K, et al. LC-HRMS method for peptide-related analytical characterization. Journal of Pharmaceutical and Biomedical Analysis. 2015.
- U.S. Food and Drug Administration. Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients. FDA Guidance. 2018.
- Tena-Sempere M. GPR54 and kisspeptin in reproduction. Human Reproduction Update. 2006. PMID: 16731583.
- UniProt Consortium. KiSS-1 receptor human entry. UniProtKB. Accessed 2026.
- Kotani M, et al. KiSS-1-derived peptides and GPR54 receptor research. Journal of Biological Chemistry. 2001. PMID: 11457843.
- Popa SM, Clifton DK, Steiner RA. Kisspeptins and GPR54 in neuroendocrine research. Annual Review of Physiology. 2008. PMID: 17988212.
- International Council for Harmonisation. ICH Q7 Guideline. ICH. 2000.
- U.S. Food and Drug Administration. ICH Q7 questions and answers guidance. FDA. 2018.
Research Disclaimer
This material is supplied strictly for in vitro laboratory research and is not for human or veterinary use. Published studies describe specific experimental materials, models, and methods; they do not establish the safety, efficacy, or suitability of this catalog product for non-research use. Review the original publications and the lot-specific analytical documentation independently.
There are no reviews yet.